From genes to pain:: Nav1.7 and human pain disorders

被引:204
|
作者
Dib-Hajj, Sulayman D.
Cummins, Theodore R.
Black, Joel A.
Waxman, Stephen G.
机构
[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA
[3] VA Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA
[4] Indiana Univ, Sch Med, Stark Neurosci Inst, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
关键词
D O I
10.1016/j.tins.2007.08.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gain-of-function mutations or dysregulated expression of voltage-gated sodium channels can produce neuronal hyperexcitability, leading to acute or chronic pain. The sodium channel Na(v)1.7 is expressed preferentially in most slowly conducting nociceptive neurons and in sympathetic neurons. Gain-of-function mutations in the Na(v)1.7 channel lead to DRG neuron hyperexcitability associated with severe pain, whereas loss of the Na(v)1.7 channel in patients leads to indifference to pain. The contribution of Na(v)1.7 to acquired and inherited pain states and the absence of motor, cognitive and cardiac deficits in patients lacking this channel make it an attractive target for the treatment of neuropathic pain.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 50 条
  • [41] Hydropathicity-based prediction of pain-causing NaV1.7 variants
    Makros N. Xenakis
    Dimos Kapetis
    Yang Yang
    Monique M. Gerrits
    Jordi Heijman
    Stephen G. Waxman
    Giuseppe Lauria
    Catharina G. Faber
    Ronald L. Westra
    Patrick J. Lindsey
    Hubert J. Smeets
    BMC Bioinformatics, 22
  • [42] Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain
    Chowdhury, Sultan
    Chafeev, Mikhail
    Liu, Shifeng
    Sun, Jianyu
    Raina, Vandna
    Chui, Ray
    Young, Wendy
    Kwan, Rainbow
    Fu, Jianmin
    Cadieux, Jay A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3676 - 3681
  • [43] Neuropathische Schmerzen durch Nav1.7-MutationenKlinik und TherapieNeuropathic pain associated with Nav1.7 mutationsClinical picture and treatment
    K. Doppler
    C. Sommer
    Der Nervenarzt, 2013, 84 : 1428 - 1435
  • [44] CNV1014802 Rescues the Paroxysmal Extreme Pain Disorders Nav1.7 Mutants by Restoring Impaired Inactivation
    Zheng, Yueming
    Wang, Wanfu
    Gao, Zhaobing
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 241A - 241A
  • [45] Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor
    Flinspach, M.
    Xu, Q.
    Piekarz, A. D.
    Fellows, R.
    Hagan, R.
    Gibbs, A.
    Liu, Y.
    Neff, R. A.
    Freedman, J.
    Eckert, W. A.
    Zhou, M.
    Bonesteel, R.
    Pennington, M. W.
    Eddinger, K. A.
    Yaksh, T. L.
    Hunter, M.
    Swanson, R. V.
    Wickenden, A. D.
    SCIENTIFIC REPORTS, 2017, 7
  • [46] A Drug Discovery Approach for an Effective Pain Therapy through Selective Inhibition of Nav1.7
    Trombetti, Gabriele A.
    Mezzelani, Alessandra
    Orro, Alessandro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [47] Discovery of a novel class of benzazepinone Nav1.7 blockers:: Potential treatments for neuropathic pain
    Hoyt, Scott B.
    London, Clare
    Gorin, David
    Wyvratt, Matthew J.
    Fisher, Michael H.
    Abbadie, Catherine
    Felix, John P.
    Garcia, Maria L.
    Li, Xiaohua
    Lyons, Kathryn A.
    McGowan, Erin
    MacIntyre, D. Euan
    Martin, William J.
    Priest, Birgit T.
    Ritter, Amy
    Smith, McHardy M.
    Warren, Vivien A.
    Williams, Brande S.
    Kaczorowski, Gregory J.
    Parsons, William H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4630 - 4634
  • [48] Strategic advances in the identification of small molecule inhibitors of NaV1.7 for the treatment of chronic pain
    Milgram, Benjamin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [49] Foxo1 selectively regulates static mechanical pain by interacting with Nav1.7
    Zhang, Xiao-Long
    Lai, Ren-Chun
    Chen, Zi-Hang
    Zhong, Xiong-Xiong
    Cao, Xian-Ying
    Zhang, Xi
    Xiao, Yi-Bin
    Wang, Jun-Chao
    Liu, Xian-Guo
    Xie, Man-Xiu
    PAIN, 2021, 162 (02) : 490 - 502
  • [50] Pharmacological characterization of a rat Nav1.7 loss-of-function model with insensitivity to pain
    Chen, Lubin
    Effraim, Philip R.
    Carrara, Jennifer
    Zhao, Peng
    Dib-Hajj, Fadia B.
    Dib-Hajj, Sulayman D.
    Waxman, Stephen G.
    PAIN, 2020, 161 (06) : 1350 - 1360